Screener
Olema Pharmaceuticals, Inc. OLMA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 57,986 | 34,873 |
| Loss from operations | (57,986) | (34,873) |
| Other income: | ||
| Interest income | 4,776 | 4,524 |
| Other income (loss) | 121 | (40) |
| Total other income | 4,897 | 4,484 |
| Net loss | $$(53,089) | (30,389) |
| Net loss per share, basic and diluted | $$(0.52) | (0.36) |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s interest income?
- Olema Pharmaceuticals, Inc. (OLMA) reported interest income of $4.78M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Olema Pharmaceuticals, Inc.'s interest income increased by 5.6% year-over-year, from $4.52M to $4.78M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s interest income has grown at a 146.1% compound annual growth rate (CAGR), from $442K to $16.22M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Olema Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude